| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/25/2005 | EP0862461B1 Methods of treating established colitis using antibodies against il-12 |
| 05/25/2005 | EP0814796B1 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
| 05/25/2005 | CN1620510A Cytokine protein family |
| 05/25/2005 | CN1620500A Corona-virus-like particles comprising functionally deleted genomes |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620461A 2-amino-propanol derivatives |
| 05/25/2005 | CN1620459A 稠合双环嘧啶衍生物 Fused bicyclic pyrimidine derivative |
| 05/25/2005 | CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 05/25/2005 | CN1620451A Benzhydryl derivatives |
| 05/25/2005 | CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620419A 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 05/25/2005 | CN1620299A Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/25/2005 | CN1618969A Mammalian sytokine-like polypeptide-10 |
| 05/25/2005 | CN1618869A Polysaccharide of basidium and its use |
| 05/25/2005 | CN1618803A Recombinated phycobiliprotein and its preparation method and application |
| 05/25/2005 | CN1618789A Macrocyclic peptides active against the hepatitis C virus |
| 05/25/2005 | CN1618466A Vaccine for treating hepatitis B, and its prepn. method |
| 05/25/2005 | CN1618453A Chewing composition for infantile digestion, and its prepn. method |
| 05/25/2005 | CN1618441A Medicinal composition for regulating blood fat, prepn. method and use thereof |
| 05/25/2005 | CN1618435A Oral liquor for promoting-blood circulation and removing blood stasis contg. Radix astragali and ginseng |
| 05/25/2005 | CN1618430A Adefovir composite medicine for treating hepatitis B |
| 05/25/2005 | CN1618323A Health-care oral liquor |
| 05/25/2005 | CN1203091C TGF (b) 1 inhibitor peptides |
| 05/25/2005 | CN1203071C Polysaccharidic esters of N-derivatives of glutamic acid |
| 05/25/2005 | CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 05/25/2005 | CN1203055C Method and composition for treating or preventing bacterial infection |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/25/2005 | CN1202857C Medicinal pill for treating gastritis and its producing process |
| 05/25/2005 | CN1202854C Chinese medicine possessing kidney supplementing, brain fortifying, statis transforming and vessel freeing actions |
| 05/25/2005 | CN1202848C Chinese herbal medicine for curing periodontitis and gingivitis and preparing process thereof |
| 05/25/2005 | CN1202844C Pediatric medicament for promoting digestion and stimulating the appetite and its preparation method |
| 05/25/2005 | CN1202839C Use of Chinese medicine prepn containing gentiamarin in preparing medicine for treating hepatosis |
| 05/25/2005 | CN1202838C Health-care rhubarb composition |
| 05/25/2005 | CN1202836C Toad skin preparation and productive process thereof |
| 05/25/2005 | CN1202835C Composition for prevention of hepatic steatosis |
| 05/25/2005 | CN1202825C Difenidol hydrochloride oral disintegrating tablet and prparation process thereof |
| 05/25/2005 | CN1202824C Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for preparing medicine for treating hepatitis virus infection |
| 05/25/2005 | CN1202820C Subprostrate sophora oral preparation, preparing method and use |
| 05/25/2005 | CN1202815C Delayed-action form of administration containing tramadol saccharinate |
| 05/25/2005 | CN1202733C Food and process for manufacturing same |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6897310 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction |
| 05/24/2005 | US6897299 Process for producing erythromycin derivative |
| 05/24/2005 | US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |
| 05/24/2005 | US6897227 Prodrugs of proton pump inhibitors |
| 05/24/2005 | US6897226 NK-1 receptor active amine oxide prodrugs |
| 05/24/2005 | US6897222 Pyrido[2,1-a]isoquinoline derivatives |
| 05/24/2005 | US6897221 Urea substituted imidazoquinolines |
| 05/24/2005 | US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents |
| 05/24/2005 | US6897218 Nitric oxide donors based on metallic centers |
| 05/24/2005 | US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 05/24/2005 | US6897206 Combinations for the treatment of inflammatory disorders |
| 05/24/2005 | US6897205 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 05/24/2005 | US6897050 Desaturase genes and their use |
| 05/24/2005 | US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters |
| 05/24/2005 | US6896910 Anti-fatigue and tonic agent containing wild ginseng |
| 05/24/2005 | CA2359031C Thiazolidinone or oxazolidinone derivatives for treatment of ulcerative disease |
| 05/24/2005 | CA2326076C Novel macrolides |
| 05/24/2005 | CA2210708C Tricyclic vasopressin antagonists |
| 05/24/2005 | CA2200935C Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 05/19/2005 | WO2005025520A3 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 05/19/2005 | WO2004075846A3 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/19/2005 | WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 05/19/2005 | US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine |
| 05/19/2005 | US20050107611 For use as adenosine receptor ligands; immunostimulants; contraceptives |
| 05/19/2005 | US20050107472 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107416 17-hydroxy 4-aza androstan -3-ones as androgen receptor modulators |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 05/19/2005 | US20050107406 Angiogenesis inhibitors |
| 05/19/2005 | US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions |
| 05/19/2005 | US20050107390 i.e. 7-[(3R)-3-Amino-4-(3,4-difluorophenyl)butanoyl]-3-methyl-6-(phenylmethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine, dihydrochloride; antilipemic, antiobesity |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107375 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 05/19/2005 | US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/19/2005 | US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease |
| 05/19/2005 | US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 05/19/2005 | US20050107291 Compositions and methods for treating or preventing diseases of body passageways |
| 05/19/2005 | US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/19/2005 | US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |